Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways-Reference-Cited by-同舟云学术

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways

Published:2014-11-21 Issue:1 Volume:125 Page:141-156
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Gomez Ivan G.,MacKenna Deidre A.,Johnson Bryce G.,Kaimal Vivek,Roach Allie M.,Ren Shuyu,Nakagawa Naoki,Xin Cuiyan,Newitt Rick,Pandya Shweta,Xia Tai-He,Liu Xueqing,Borza Dorin-Bogdan,Grafals Monica,Shankland Stuart J.,Himmelfarb Jonathan,Portilla Didier,Liu Shiguang,Chau B. Nelson,Duffield Jeremy S.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference53 articles.

1. Identification of a microRNA signature of renal ischemia reperfusion injury

2. MicroRNA Circuits in Transforming Growth Factor-β Actions and Diabetic Nephropathy

3. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

4. MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways

5. Therapy for Fibrotic Diseases: Nearing the Starting Line

Cited by 342 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of perirenal adipose tissue deposition in chronic kidney disease progression: Mechanisms and therapeutic implications;Life Sciences;2024-09

2. Advances in Antisense Oligo Technology for Sustainable Crop Protection;Critical Reviews in Plant Sciences;2024-08-28

3. Altered Host microRNAomics in HIV Infections: Therapeutic Potentials and Limitations;International Journal of Molecular Sciences;2024-08-13

4. Glucosylceramide synthase modulation ameliorates murine renal pathologies and promotes macrophage effector function in vitro;Communications Biology;2024-08-02

5. Targeted gene therapy for rare genetic kidney diseases;Kidney International;2024-08